Effect of siltuximab on lean body mass (LBM) in multicentric Castleman's disease (MCD) patients (pts).

被引:0
|
作者
Sawyer, Michael B.
Casper, Corey
Munshi, Nikhil C.
Wong, Raymond
Vermeulen, Jessica
Bandekar, Rajesh
Qi, Ming
Van de Velde, Helgi
Van Rhee, Frits
机构
[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China
[5] Janssen Res & Dev, Leiden, Netherlands
[6] Janssen Res & Dev, Spring House, PA USA
[7] Janssen Res & Dev, Beerse, Belgium
[8] Myeloma Inst Res & Therapy, Little Rock, AR USA
关键词
D O I
10.1200/jco.2014.32.15_suppl.8576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8576
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Efficacy of siltuximab in patients with previously treated multicentric Castleman's disease (MCD).
    Van Rhee, Frits
    Munshi, Nikhil C.
    Wong, Raymond
    Ke, Xiaoyan
    Fossa, Alexander
    Simpson, David
    Dispenzieri, Angela
    Lechowicz, Mary Jo
    Kuruvilla, John
    Bandekar, Rajesh
    Qin, Xiang
    Qi, Ming
    Vermeulen, Jessica
    Casper, Corey
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Dose selection of siltuximab for multicentric Castleman’s disease
    Christina L. Mayer
    Lanyi Xie
    Rajesh Bandekar
    Ming Qi
    Helgi van de Velde
    Manjula Reddy
    Xiang Qin
    Hugh M. Davis
    Thomas A. Puchalski
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 1037 - 1045
  • [3] Review of siltuximab in the treatment of multicentric Castleman's disease
    Sarosiek, Shayna
    Shah, Ruchit
    Munshi, Nikhil C.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (06) : 360 - 366
  • [4] Dose selection of siltuximab for multicentric Castleman's disease
    Mayer, Christina L.
    Xie, Lanyi
    Bandekar, Rajesh
    Qi, Ming
    van de Velde, Helgi
    Reddy, Manjula
    Qin, Xiang
    Davis, Hugh M.
    Puchalski, Thomas A.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 1037 - 1045
  • [5] FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
    Deisseroth, Albert
    Ko, Chia-Wen
    Nie, Lei
    Zirkelbach, Jeanne F.
    Zhao, Liang
    Bullock, Julie
    Mehrotra, Nitin
    Del Valle, Pedro
    Saber, Haleh
    Sheth, Christopher
    Gehrke, Brenda
    Justice, Robert
    Farrell, Ann
    Pazdur, Richard
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (05) : 950 - 954
  • [6] IMPROVEMENTS IN HEMOGLOBIN LEVELS AND FATIGUE IN A RANDOMIZED, DOUBLE BLINDED, PLACEBO CONTROLLED STUDY (MCD3282001) OF SILTUXIMAB IN PATIENTS WITH MULTICENTRIC CASTLEMAN'S DISEASE (MCD)
    Van Rhee, F.
    Fossa, A.
    van de Velde, H.
    Qi, M.
    Ho, K. F.
    Fleming, S.
    Vermeulen, J.
    Rothman, M.
    Casper, C.
    [J]. HAEMATOLOGICA, 2014, 99 : 464 - 465
  • [7] Analysis of multicentric Castleman's disease (MCD) with pulmonary lesions
    Ikushima, Soichiro
    Terasaki, Yasuhiro
    Hebisawa, Akira
    Johko, Takeshi
    Sakai, Fumikazu
    Nishimoto, Norihiro
    Ogura, Takashi
    Ohta, Yasunori
    Ishii, Haruyuki
    Matsui, Shoko
    Yamamoto, Hiroshi
    Ichimura, Yasunori
    Ujita, Masuo
    Kawamura, Tetsuharu
    Bando, Masashi
    Ishimoto, Hiroshi
    Izumi, Shinyu
    Hata, Norihiko
    Tomii, Keisuke
    Owan, Isoko
    Kimura, Hiroshi
    Komase, Yuko
    Matsuzawa, Yasuo
    Arita, Machiko
    Shiraki, Akira
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease
    Sitenga, Jenna
    Aird, Gregory
    Ahmed, Aabra
    Silberstein, Peter T.
    [J]. PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 35 - 41
  • [9] The clinical, laboratory, and radiologic improvement due to siltuximab treatment in idiopathic multicentric Castleman's disease
    Min, Gi-June
    Jeon, Young-Woo
    Park, Sung-Soo
    Park, Silvia
    Shin, Seung-Hawn
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Kim, Dong-Wook
    Lee, Jong-Wook
    Cho, Seok-Goo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 424 - 432
  • [10] Multicentric Castleman's disease (MCD) - a rare differential diagnosis in patients with generalized lymphadenopathy and recurrent fever
    Echterdiek, F.
    Holl, H. -G.
    Kasenda, B.
    Illerhaus, G.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 65 - +